Successful desensitization to idursulfase in a patient with type II mucopolysaccharidosis (hunter syndrome)

Journal of Investigational Allergology and Clinical Immunology

Volumn 21, Issue 7, 2011, Pages 571-572

  Serrano, C D ^a   Gomez, J F ^a  

^a FUNDACIÓN VALLE DEL LILI   (Colombia)

Author keywords

Desensitization; Hunter syndrome; Idursulfase

Indexed keywords

CLEMASTINE; HYDROCORTISONE; IDURONATE 2 SULFATASE;

AORTA VALVE STENOSIS; ARTICLE; CASE REPORT; CHILD; DESENSITIZATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HUMAN; HUNTER SYNDROME; HYPOACUSIS; INFUSION RATE; INTRACUTANEOUS TEST; MALE; PRICK TEST; SCHOOL CHILD; SEIZURE; UMBILICAL HERNIA; UPPER RESPIRATORY TRACT OBSTRUCTION; URTICARIA;

CHILD; DESENSITIZATION, IMMUNOLOGIC; ENZYME REPLACEMENT THERAPY; HUMANS; IDURONATE SULFATASE; MALE; MUCOPOLYSACCHARIDOSIS II;

EID: 83755206485     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Wraith JE, Scarpa M, Beck M, Bodamer OA, De Meirleir L, Guffon N, Meldgaard Lund A, Malm G, Van der Ploeg AT, Zeman J. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy. Eur J Pediatr 2008; 167: 267-77.
2. Muenzer J, Gucsavas-Calikoglu M, McCandless SE, Schuetz TJ, Kimura A. A phase I/II clinical trial of enzyme replacement therapy in mucopolysaccharidosis II (Hunter syndrome). Mol Genet Metab 2007; 90: 329-37.
3. Muenzer J, Beck M, Eng CM, Giugliani R, Harmatz P, Martin R, Ramaswami U, Vellodi A, Wraith JE, Cleary M, Gucsavas-Calikoglu M, Puga AC, Shinawi M, Ulbrich B, Vijayaraghavan S, Wendt S, Conway AM, Rossi A, Whiteman DA, Kimura A. Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome. Genet Med 2011; 13: 95-101.
4. Muenzer J, Wraith JE, Beck M, Giugliani R, Harmatz P, Eng CM, Vellodi A, Martin R, Ramaswami U, Gucsavas-Calikoglu M, Vijayaraghavan S, Wendt S, Puga AC, Ulbrich B, Shinawi M, Cleary M, Piper D, Conway AM, Kimura A. A phase II/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome). Genet Med 2006; 8: 465-73.
5. Muenzer J, Beck M, Eng CM, Escolar ML, Giugliani R, Guffon NH, Harmatz P, Kamin W, Kampmann C, Koseoglu ST, Link B, Martin RA, Molter DW, Muñoz Rojas MV, Ogilvie JW, Parini R, Ramaswami U, Scarpa M, Schwartz IV, Wood RE, Wraith E. Multidisciplinary management of Hunter syndrome. Pediatrics 2009; 124: e1228-39.